| TAZEMETOSTAT HYDROBROMIDE | None | ||
| 200MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| TAZVERIK is a methyltransferase inhibitor indicated for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. | |||
|
Yes
| |||
| TAZVERIK | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 | Patent 25 | Patent 26 | Patent 27 | Patent 28 | Patent 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||||||||||
| ****- ** **********-*********** ******* ********* | ********** ** ***** **** *** ******* ** *** ******* | ****- ** **********-*********** ******* ********* | ********** ** ***** **** *** ******* ** *** ******* | ****- ** **********-*********** ******* ********* | ********** ** ***** ****, *** ******* ** *** ******* | ********** ** ***** ****, *** ******* ** *** ******* | ********** ** ***** ****, *** ******* ** *** ******* | **** **** ** * ***** ******* ***************** **** ********* | ****- ** **********-*********** ******* ********* | ****- ** **********-*********** ******* ********* | ******* ** ******** ****** | ****-** **********-*********** ******* ********* | **** **** ** * ***** ******* ***************** **** ********* | ****** *** ******** ****** | ********** ** ***** ****, *** ******* ** *** ******* | ****- ** **********-*********** ******* ********* | **** **** ** * ***** ******* ***************** **** ********* | ****** *** ******** ****** | ****-** **********-*********** ******* ********* | ****** *** ******** ****** | **** **** ** * ***** ******* ***************** **** ********* | ****-** **********-*********** ******* ********* | **** **** ** * ***** ******* ***************** **** ********* | ****-** **********-*********** ******* ********* | ******* ** ******** ****** | ****** *** ******** ****** | ****-** **********-*********** ******* ********* | ****-** **********-*********** ******* ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|